The IL12B Gene Psoriasis Susceptibility Type 11 Genetic Test is a specialized diagnostic assessment conducted at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify specific genetic markers associated with Psoriasis Susceptibility Type 11, linked to the IL12B gene. The IL12B gene plays a crucial role in the immune system by encoding components of interleukin-12 (IL-12), which is essential for the differentiation of T cells and has been implicated in the pathogenesis of psoriasis. By analyzing an individual's genetic makeup, this test can help in understanding the genetic predisposition to psoriasis, allowing for a more tailored approach to management and treatment of the condition. It serves as a valuable tool for individuals with a family history of psoriasis or those experiencing symptoms, providing insights into their genetic risk factors.
The CARD14 Gene Psoriasis Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the CARD14 gene that are associated with Psoriasis Type 2. Psoriasis is a chronic autoimmune skin condition characterized by red, flaky, crusty patches of skin covered with silvery scales. The involvement of the CARD14 gene in Psoriasis Type 2 highlights the genetic predisposition in the development of this condition, making this test crucial for individuals with a family history of psoriasis or those exhibiting symptoms.
By analyzing the genetic material for specific mutations in the CARD14 gene, the test provides valuable insights into the individual's genetic risk of developing Psoriasis Type 2. This information can be instrumental in the early diagnosis and management of the condition, allowing for tailored treatment plans that can significantly improve the quality of life for those affected.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, ensuring high standards of accuracy and reliability. The cost of the CARD14 Gene Psoriasis Type 2 Genetic Test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the expertise involved in interpreting the results.
The "IL36RN Gene Psoriasis Generalized Pustular Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the IL36RN gene, which are associated with Generalized Pustular Psoriasis (GPP). This rare and severe form of psoriasis is characterized by widespread pustules on a background of red and tender skin. The IL36RN gene plays a crucial role in skin inflammation and immune response, and mutations in this gene can lead to an exaggerated inflammatory response, manifesting as GPP.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in a laboratory setting to identify any genetic abnormalities in the IL36RN gene. Identifying mutations in this gene can help in confirming the diagnosis of GPP, understanding the disease's genetic basis, and potentially guiding personalized treatment options.
This genetic test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used in identifying the genetic mutations associated with Generalized Pustular Psoriasis. By offering this test, DNA Labs UAE provides critical support in the diagnosis and management of patients suffering from this challenging condition, paving the way for more targeted and effective treatments.
The CHRNG Gene Pterygium Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the CHRNG gene, which are associated with Pterygium Syndrome. Pterygium Syndrome is a rare genetic condition characterized by the development of web-like skin formations, typically across joints, restricting movement, and may be accompanied by other musculoskeletal abnormalities. The CHRNG gene plays a crucial role in the development and function of the neuromuscular junction, and mutations in this gene can lead to the symptoms observed in Pterygium Syndrome.
This genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the CHRNG gene that might be responsible for the condition. It is a critical step for families seeking answers for congenital conditions, providing them with essential information for management, treatment planning, and understanding the risk of recurrence in future pregnancies.
The cost of the CHRNG Gene Pterygium Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, encompassing the collection of the sample, the sophisticated genetic analysis, and the detailed report provided by the lab's genetic experts. For families affected by Pterygium Syndrome or individuals at risk, this test represents a crucial investment in their health and future well-being.
The TERT Gene Pulmonary Fibrosis and/or Bone Marrow Failure Telomere-Related Type 1 Genetic Test is a sophisticated diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TERT gene. These mutations are linked to telomere biology disorders, specifically pulmonary fibrosis and bone marrow failure, conditions characterized by the premature shortening of telomeres. Telomeres are protective caps at the ends of chromosomes, essential for maintaining genomic stability. Mutations in the TERT gene, which encodes the telomerase reverse transcriptase, can lead to inadequate telomere length maintenance, contributing to cellular aging and the development of related diseases.
The test, priced at 4400 AED, offers critical insights for individuals with a family history of these conditions or presenting symptoms suggesting these disorders. By pinpointing the genetic underpinnings, the test facilitates targeted management strategies, potentially improving patient outcomes through personalized medicine. Conducted at DNA Labs UAE, a facility known for its cutting-edge genetic testing services, this test represents a crucial step in diagnosing and understanding the genetic factors contributing to telomere-related disorders.
The "AMER1 Gene Osteopathia Striata with Cranial Sclerosis Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the AMER1 gene. This gene plays a crucial role in bone development and density, and mutations can lead to osteopathia striata with cranial sclerosis (OSCS), a rare genetic disorder characterized by striations in the bones, particularly in the pelvis and long bones, along with sclerosis (hardening) of the cranial bones. The condition may also present with other physical anomalies and developmental challenges.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the AMER1 gene. This precise genetic testing is vital for early diagnosis, allowing for appropriate management and treatment plans to be established for individuals affected by OSCS. Moreover, it can provide essential information for family planning and genetic counseling for families with a history of this disorder. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering a crucial resource for individuals and families dealing with OSCS.
The SNX10 gene osteopetrosis of infancy malignant genetic test is a specialized diagnostic procedure designed to identify mutations in the SNX10 gene, which are known to cause a severe form of osteopetrosis. Osteopetrosis, also known as "marble bone disease," is a rare genetic disorder characterized by the abnormal densification of bone, leading to various complications such as bone fragility, impaired hematopoiesis, and stunted growth. The infantile malignant form is particularly severe and can be life-threatening if not diagnosed and managed early.
This genetic test involves analyzing the patient's DNA to detect mutations in the SNX10 gene, which plays a crucial role in the development and function of osteoclasts, the cells responsible for bone resorption. A mutation in this gene disrupts the normal bone remodeling process, resulting in the excessive bone density typical of osteopetrosis.
Conducted at DNA Labs UAE, the test is priced at 4400 AED. It is recommended for infants who present symptoms suggestive of osteopetrosis, such as failure to thrive, frequent bone fractures, or abnormal bone imaging findings, as well as for families with a known history of the disease. Early and accurate diagnosis through this genetic test can facilitate timely intervention and management, potentially improving outcomes for affected infants.
The CLCN7 Gene Osteopetrosis Autosomal Dominant Type 1 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the CLCN7 gene, which are known to cause Autosomal Dominant Osteopetrosis Type 1 (ADO1). This condition is characterized by an increased bone density and abnormal bone growth, leading to a variety of health issues including bone fragility, neurological complications, and impaired function of bone marrow. The test is crucial for early diagnosis and management of the condition, allowing for better prognosis and targeted treatments.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify any mutations in the CLCN7 gene that are indicative of ADO1. The process is comprehensive, ensuring high accuracy and reliability in the results. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to perform this intricate analysis.
By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and manage the condition more effectively. DNA Labs UAE offers state-of-the-art facilities and a team of genetic experts to guide patients through the testing process, ensuring a seamless and informative experience.
The TCIRG1 gene osteopetrosis autosomal recessive type 1 genetic test is a specialized diagnostic procedure designed to identify mutations in the TCIRG1 gene, which are responsible for causing autosomal recessive osteopetrosis type 1 (ARO). ARO is a rare genetic disorder characterized by increased bone density and abnormal bone growth due to defective osteoclast function, which can lead to a variety of health issues including bone fragility, stunted growth, and neurological complications. This test is crucial for early diagnosis and management of the condition, allowing for appropriate treatment and intervention strategies to be implemented.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory to detect any genetic mutations in the TCIRG1 gene. The cost of the test is 4400 AED, making it a valuable investment for families with a history of the condition or for individuals showing symptoms suggestive of osteopetrosis. Early and accurate diagnosis through this genetic test can significantly improve the quality of life for affected individuals by enabling targeted treatment approaches and genetic counseling for families.
The TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool used to identify mutations in the TNFSF11 gene, which are responsible for causing Osteopetrosis Autosomal Recessive Type 2 (OPTA2). This condition is a rare genetic disorder characterized by increased bone density and abnormal bone growth, leading to a range of complications such as bone fragility, abnormal posture, and in severe cases, neurological issues due to nerve compression.
The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. By analyzing a patient's DNA sample, usually obtained through a blood draw, the test can pinpoint specific genetic alterations in the TNFSF11 gene that are indicative of OPTA2. This information is crucial for confirming the diagnosis, understanding the disease's progression, and tailoring a treatment plan that addresses the patient's specific needs.
The cost of the TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, from the initial DNA extraction to the detailed analysis and reporting of results. Given the complexity of OPTA2 and the importance of early and accurate diagnosis in managing the condition, this test represents a valuable investment in a patient's health and well-being.
